Media Update, page-854

+ @buildabridge

slight correction if I may.

The South African site is dedicated to HIV test production as well as internal R&D. Blisters (a key internal component) come from the USA site where the 1st blister machine is located. Remainder HIV kit components come from China suppliers and the HIV site exclusively produces HIV kits for all markets/rebranded tests/distros.

There is no manufacturing site for AT1 kits yet in USA. As we know there is some talk about this but for AT1 owned kits or for OEM supply or mixed use is unknown.

The OEM devices for various agreements have components made by China suppliers. The blister component again is solely supplied from AT1's USA site. The 2nd blister production machine being installed in Sydney (2021) will boost this OEM device capacity. South Africa would have R&D aspect for this but no OEM device/kit production.

Overall, no complete e2e OEM device based kit production exists in AT1 (yet)...as the point is that the test owner/manufacturer (AccBio, NG Bio, LDX) co-develops the test kit and then gets all the required components manufactured by AT1's chain for final assembly (with their proprietary test strip), testing and distribution from their own factories to wherever (at which point AT1 itself might signed up as a distro for the full kit (eg: AccessBio integrated device Ag RDT + NG Bio integrated device Ab RDT)

The AccBio Ag tests (non-OEM device) are made by AccessBio only and we are a distro/reseller . Likewise the NG Bio Ab kit (using AT1 OEM device) is produced in France (and follows the same supply chains from China/USA for the components).

Hope that helps clarify.